Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation

被引：0
|
作者：
B. Noiret
G. Piessen
C. Eveno
机构：
[1] Claude Huriez University Hospital,Department of Digestive and Oncological Surgery
[2] UMR-S1277 – CANTHER Laboratory “Cancer Heterogeneity,undefined
[3] Plasticity and Resistance to Therapies”,undefined
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5448 / 5449
页数：1
相关论文
共 50 条
  • [1] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation
    Noiret, B.
    Piessen, G.
    Eveno, C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 5448 - 5449
  • [2] Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation”
    Philipp Horvath
    Can Yurttas
    [J]. Annals of Surgical Oncology, 2021, 28 : 5450 - 5451
  • [3] Reply to: "Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation"
    Horvath, Philipp
    Yurttas, Can
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 5450 - 5451
  • [4] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma
    Tan, Grace H. C.
    Cheung, Michelle
    Chanyaputhipong, Jendana
    Soo, Khee Chee
    Teo, Melissa C. C.
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2013, 42 (06) : 291 - 296
  • [5] Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Tan, Grace Hwei Ching
    Chia, Claramae Shulyn
    Tan, Sze Huey
    Soo, Khee Chee
    Teo, Melissa Ching Ching
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 989 - 998
  • [6] The quest of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): searching for evidence
    Reymond, Marc A.
    [J]. PLEURA AND PERITONEUM, 2016, 1 (04) : 167 - 168
  • [7] Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Acs, Miklos
    Babucke, Maximilian
    Jusufi, Maximilian
    Kaposztas, Zsolt
    Slowik, Przemyslaw
    Hornung, Matthias
    Schlitt, Hans J.
    Panczel, Ivan
    Hevesi, Judit
    Herzberg, Jonas
    Strate, Tim
    Piso, Pompiliu
    [J]. INNOVATIVE SURGICAL SCIENCES, 2024, 9 (01): : 3 - 15
  • [8] Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Grace Hwei Ching Tan
    Claramae Shulyn Chia
    Sze Huey Tan
    Khee Chee Soo
    Melissa Ching Ching Teo
    [J]. International Journal of Clinical Oncology, 2018, 23 : 989 - 998
  • [9] Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
    Mouw, Tyler J.
    Lu, Jennifer
    Woody-Fowler, Meghan
    Ashcraft, John
    Valentino, Joseph
    DiPasco, Peter
    Mammen, Joshua
    Al-Kasspooles, Mazin
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 828 - 832
  • [10] Malignant Struma Ovarii Treated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Acs, Miklos
    Haeusler, Sebastian
    Lighvani, Hamid-Reza
    Zustin, Jozef
    Piso, Pompiliu
    [J]. IN VIVO, 2021, 35 (06): : 3591 - 3596
12345